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I. INTRODUCTION 
Phosphatidylcholine and lysophosphatidylcholine 
Phosphatidylcholine (PC) is the major membrane 
phospholipid class in mammalian cells (1). It constitutes about 
one half of the phospholipids in eukaryotic cells and over half of 
serum phospholipids (1). 
PC has a number of roles in the cell. In membranes the lipid 
plays a structural role and in serum lipoproteins it is present as a 
monolayer shell surrounding a core of nonpolar lipids (1). It 
serves as a substrate for lecithin:cholesterol acyltransferase in 
the plasma fraction of blood wherein it plays a role in cholesterol 
transport in the blood stream (2). In the form of dipalmitoyl PC, it 
is a critical component of pulmonary surfactant (2). In recent 
years, PC has attracted attention through the suggestion that it 
has a role as a substrate for the production of second messengers 
(3). 
LPC generated from the hydrolysis of a fatty acid from PC 
also occurs naturally in mammalian tissues though at very much 2 
lower levels than PC (1). However, it is a significant component of 
blood plasma and plays many physiological role. 
Phosphatidylcholine biosynthesis 
Free choline is brought into most non-neuronal cells by 
facilitated diffusion through a specific carrier-mediated transport 
mechanism (2). It is now well established that there are two 
distinct transport mechanisms for choline. One is a high-affinity 
< 5 pM) NW-dependent, and hemicholinium-3-sensitive 
mechanism tightly coupled to acetylcholine synthesis in 
cholinergic synaptosomes. The other is a low-affinity (K. > 30 
pM), relatively NW-independent and hemicholinium-3-insensitive 
mechanism found in most animal cells as well as in cholinergic 
nerve tissues. A situation in which the rate of choline transport is 
increased by increasing its substrate supply indicates that 
choline transport is not regulated. A nonsaturable component for 
choline transport has been detected in perfused rat liver (4), 
cultured rat hepatocyte (5), Ehrlich ascites cells (6), Novikoff 
hepatoma cells (7), and human erythrocytes (8). If choline 
transport is at equilibrium, then the effect of the increased 
extracellular choline is simply to increase the level of 3 
intracellular choline, which then increases the rate of choline 
kinase. 
The choline taken up is incorporated into PC via the CDP­
choline pathway as shown in Figure 1 (9). Cho line kinase 
catalyzes the first committed step, phosphorylation of choline to 
form phosphocholine. Phosphocholine and CTP are then 
converted to CDP-choline by CTP:phosphocholine 
cytidylyltransferase, and finally CDP-choline is incorporated into 
PC by choline phosphotransferase. 
PC biosynthesis is mostly regulated by the enzyme 
CTP:phosphocholine cytidylyltransferase (9) which becomes 
active when it translocates from cytosol to endoplasmic reticulum 
membrane. There is evidence to suggest that free fatty acid 
stimulates this translocation. It has been reported that cellular 
PC biosynthesis is significantly elevated in 3T3 cells transformed 
with the Ha-ras oncogene through an increase in the cellular 
phosphocholine pool as a consequence of an activated choline 
kinase (14). 
PC may also be synthesized by methylation of 
phosphatidylethanolamine with S-adenosylmethionine (1). Vance 
et al showed in rat hepatocytes that the PC pool synthesized from 
the CDP-choline pathway is preferred for PC secretion due to the 4 
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Figure 1. The PC synthesis and degradation pathway.5 
fact that the specific radioactivity of PC derived from 
[Me- 3H)choline was approximately equal in cells and medium (50). 
They also showed by measuring the medium and cellular specific 
radioactivity that although PC from the methylation of 
phosphatidylethanolamine, derived from ethanolamine, is not 
preferred for secretion, PC from the methylation of PE derived 
from serine is a preferred source of PC for secretion. This fact 
indicates that random and homogeneous PC pools are not 
selected for PC secretion. Similar conclusions were reported by 
Brindley et al (38). They observed a lower production of 20:4 fatty 
acid in cellular LPC from rat hepatocytes despite high production 
of this fatty acid in cellular PC. This suggests that a specific pool 
of PC molecular species is selected for PC turnover into LPC. 
Phosphatidylcholine degradation 
It has long been known that certain hormones, growth 
factors, and phorbol esters stimulate both PC synthesis (9-11) and 
PC hydrolysis (12,13) in 3T3 cell lines and other cells. These 
factors thereby increase the PC turnover rate. 
Since PC degradation can lead to the release of arachidonic 
acid and diacylglycerol, the PC turnover cycle is recognized as a 6 
potential source of these second messengers during signal 
transduction by hormones, i.e. it may serve as a means of long 
term maintenance of the level of diacylglycerol produced by the 
well known signal transduction pathway via the hydrolysis of 
phosphatidylinositol- 4,5- bisphosphate (3,15). In this context, G-
proteins are implicated in the coupling of agonist receptors to the 
activation of phospholipases A1, A2, C, and D. Figure 2 outlines 
this turnover cycle in mammalian cells. 
Membrane PC and LPC exist in a dynamic flux in which 
continuous biosynthesis is balanced by degradation (9). 
Experiments using isolated organs, tissue slices and homogenates 
have shown that the half-lives of cellular PC vary among different 
tissues from 1.2 hour in rat liver to 1350 hours in rat brain cells 
(16). The considerable variation of half-lives was found to be 
independent of the precursor used. This indicates that the rate of 
cellular LPC production from PC will vary among different 
tissues. Interestingly, studies with cells in tissue culture have 
shown that PC turnover was similar for growing and nongrowing 
cells under conditions where no secretion of phospholipids into 
the medium took place (16). 
Lysophosphatidylcholine metabolism7 
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Figure 2. PC turnover cycles. The DAG, PC, LPC, GPC, G3P, PE, and PA means diacylglycerols,  phosphatidylcholine,
lysophosphatidylcholine,  glycerophosphatidylcholine,  glycerol -3­
phosphate, phosphatidylethanolamine, and  phosphatidic  acid 
respectively. The PLA PLA2, PLC, and PLD represent phospholipase
Al, A2, C, and D. 8 
LPC generated during PC metabolism may be converted to 
PC through reacylation or to glycerophosphocholine (GPC) by 
hydrolysis of the remaining fatty acid (figure 2). Two enzymes are 
responsible for the acylation of LPC (2). Lysolecithin 
acyltransferase transfers a fatty acyl-CoA to the 2-position of 1­
acyl-LPC whereas 2-acylglycerophosphocholine acyltransferase 
transfers a fatty acyl-CoA to the 1-position of 2-acyl-LPC. These 
reactions have been shown to be very important for the synthesis 
of PC in liver. 
However, a quite different type of acylation of LPC was 
discovered by Marinetti (17). The reaction requires two molecules 
of 1-acyl-LPC and yields PC and GPC. This pathway was 
considered of only minor importance in liver but a major 
pathway in lung. 
LPC can be further degraded by lysophospholipase which 
converts it to a fatty acid and GPC. The GPC is known to be 
subsequently hydrolyzed to choline and glycerol phosphate, or 
glycerol and phosphocholine by a phosphodiesterase (2). 
Physiological role of lysophosphatidylcholine 
At present it is unknown whether LPC, generated in the PC9 
turnover cycle, may play any role in signal transduction.
However, LPC seems to play important physiological roles either 
in the form of cellular LPC or as plasma LPC. Cellular LPC 
constitutes less then 2% of the total phospholipids in the 
membranes of most cells (1) but it is present in significant 
amounts in plasma (18). The circulating plasma LPC exerts 
several important physiological effects. It affects platelet 
aggregation (19), erythrocyte agglutination(20), and cardiac 
arrhythmia (21). It also acts as the binder of low density 
lipoprotein to arterial cells (22) and as a chemotactic factor for 
human monocytes (23). A decrease in protein-mediated glucose 
transport in red blood cells also occurs with physiological 
concentrations of LPC (24). The demyelination of various 
mammalian nerve tissues by LPC has also been observed (25-29). 
Plasma LPC are mostly produced in the plasma by the 
action of lecithin-cholesterol acyltransferase (30), which catalyzes 
the transfer of a fatty acid from the 2-position of PC to 
cholesterol. In this case LPC is a coproduct with the formation of 
cholesterol esters. Since LPC is readily taken up by cells, the 
circulating plasma LPC may be regarded as a source of fatty acid 
and choline by extravascular tissues (31). However, plasma LPC 
has also been shown to originate directly from liver in addition to 10 
being generated by plasma lecithin-cholesterol acyltransferase 
(32). It has been reported that albumin stimulates the release of 
LPC from isolated perfused rat liver (32) and monolayer cultures 
of rat hepatocyte (34-38). The released LPC from the liver and 
hepatocyte appear to be formed by the action of phospholipase A, 
or A2 on cellular PC. This hepatic LPC is predominantly 
unsaturated, which is markedly dissimilar from the highly 
saturated LPC synthesized by plasma lecithin-cholesterol 
acyltransferase activity in plasma. In the previous work (34-38), it 
was proposed that LPC secreted from liver is a major source of 
plasma lysophosphatidykholine due to the fact that LPC 
concentration in the plasma remains relatively high even in 
patients suffering from a deficiency of lecithin-cholesterol 
acyltransferase (39). 
Cho line-Lipid research On Hep-G2, 3T3, and 3T3-H.ras cells 
Cell culture systems of eukaryotic tissues have provided 
many insights into biochemical pathways and mechanisms. 
Metabolic studies of tissues and tissue-derived tumors have been 
greatly facilitated by the isolation of cell cultures. The 
manipulation of culture conditions has permitted studies of 11 
nutrient requirements and the role of hormones and other factors 
on metabolic pathways. In addition, comparison of the 
biochemistry of a specific cell type and its transformant is made 
much simpler. The fact that many cell lines are immortal allows 
one to dispense with the sacrificing of laboratory animals to 
carry out metabolic studies. 
Hep-G2, a liver cell line derived from a human hepatoma 
that is free of known hepatotropic viral agents, has been found to 
express a wide variety of liver-specific metabolic functions 
including cholesterol and triglyceride metabolism (40). The lipid 
composition of Hep G2 cells is close to that of normal human 
liver, except for a higher content of sphingomyelin and a lower 
PC/sphingomyelin ratio (41). Studies on the effects of fatty acids 
on PC synthesis in Hep-G2 have shown that CTP:phosphocholine 
cytidylyltransferase activity was increased by free fatty acid only 
in membrane fractions (42) as in the case of mammalian 
hepatocytes. 
3T3 cells, undifferentiated fibroblasts, have served as a good 
model for the action of hormones and growth factors on 
peripheral tissues. Thus, it is not surprising that most recent 
papers on PC metabolism in 3T3 cells deal with the signal 
transduction through PC hydrolysis either by phospholipase C or 12 
by phospholipase D. Warden and Friedkin have reported that 
treatment of Swiss Ba lb c 3T3 mouse embryo fibroblast with fetal 
bovine serum increased the intracellular choline kinase activity 
by 2-3 fold. This led to an increased pool size of phosphocholine 
and enhanced PC biosynthesis (10). The PC hydrolysis in second 
messenger generation in 3T3 cells has been demonstrated by the 
finding that phospholipase D-mediated hydrolysis of PC can be 
activated by various growth factors and hormones (44). 1,2­
Diacylglycerol, produced from phospholipase C and also as a 
product of phospholipase D in combination with phosphatidate 
phosphatase, is known to stimulate protein kinase C. 
Chatopadhyay et al. showed that the activated protein kinase C 
stimulates PC synthesis but the increased PC hydrolysis by 
protein kinase C activators is not necessarily associated with 
increased PC synthesis (45). However, there is evidence for a PC-
specific phospholipase C, which may be responsible for the 
activation of PC turnover in 3T3 cells (46,47) and also DNA 
synthesis activation (47). 
In 3T3 cells transformed by the H.ras oncogene, increased 
diacylglycerol levels have been found, which most probably arise 
from activation of the turnover of PC (48). Interestingly, the 
elevated cellular phosphocholine pool via increased choline 13 
kinase activity was also observed in H.ras-transformed 3T3 cells 
(14). Diacyiglycerol is a key activator of protein kinase C, whose 
role in cell growth and transformation has been proposed. It is 
known that the protein kinase C translocates from the cytosol to 
the plasma membrane during stimulation of the enzyme. Diaz-
Laviada et al showed by using immunochemical techniques that 
transformation by H.ras oncogene is associated with permanent 
translocation of protein kinase C to the cytoplasmic membrane to 
activate permanently the enzyme without down regulation (49). 
Purpose of this research 
Based on the observation that albumin stimulates the 
release of LPC from monolayer cultures of rat hepatocytes, we 
first examined whether this albumin-stimulated secretion of LPC 
is unique to hepatocytes or is a phenomenon which might be 
displayed by undifferentiated and also transformed cells which 
have active lipid metabolism. For this purpose, we used the three 
cell lines, 3T3, 3T3-H.ras, and Hep G2. 
PC is a prominent component of all plasma lipoproteins and 
made both by the CDP-choline pathway and by methylation of 14 
phosphatidylethanolamine in the liver (1). Since Vance et al had 
already shown that the PC secreted by hepatocytes originates 
from a selected cellular PC pool, the second objective of this 
research was to compare the specific radioactivities of cellular 
and secreted PC and LPC pools generated from [3H- Me]choline. 
Such a comparison might enable us to establish whether the 
secreted LPC has an origin different from that selected for PC 
secretion. 
In previous studies (31,35-38), it was proposed that the 
release of LPC from rat hepatocytes stimulated by albumin 
results from the ability of albumin to bind to cellular LPC located 
in the plasma membrane. Cancer cells show different and 
decreased amounts of glycoprotein and glycolipids in the cell 
membranes compared with host cells (51,57). Differences are also 
observed in membrane-bound proteolytic enzymes and the cell 
skeleton (51). However, tests so far show that the phospholipids 
are unchanged in cancer-transformed cells (51). Comparisons of 
the rates of LPC secretion between 3T3 and 3T3-H.ras cells and of 
the previously studied rat hepatocytes with Hep G2 might reveal 
differences which correlate with the difference in theirplasma 
membrane structures resulting from the transformations. 15 
II. MATERIALS AND METHODS 
Materials. 
Fetal-calf serum and powdered formulations of Ham's F-12 
nutrient mixture (HAMS), high-glucose Dulbecco's modified 
Eagles medium (MEM), and choline and methionine-free Eagle's 
minimum (MEM-) medium were obtained from Gibco Laboratories 
(Island, New York, USA). [Me-811]choline chloride (specific 
radioactivity 76 Ci/mmol; radiochemical purity 98 %) was 
obtained from Amersham Corporation (Arlington Heights, IL, 
USA). Coomassie brilliant blue G-250 reagent was from Bio-Rad 
Laboratories, Richmond, CA, USA. Silica gel G tic (20x20 cm) tic 
plates were from Alltech Associates, Inc., 2051 Waukegan Road, 
Deerfield, IL 60015, USA. Fatty acid-free albumin, trypsin, and all 
other chemicals were reagent grade and obtained from Sigma 
Chemical Co., St. Louis, MO, USA. Cell culture Falcon dishes 
(60mmX15mm) were obtained from Fisher Scientific Co., 
Pittsburg, PA, U.S.A.. 16 
Cell lines. 
All the cell lines used in this study were kindly provided by 
Dr. David Barnes, Department of Biochemistry and Biophysics, 
Oregon State University. The human hepatocellular carcinoma 
cell line Hep G2 and mouse embryo fibroblast BALBc/3T3 clone 
A31 cell line (3T3) were from the American Type Culture 
Collection (ATCC) cell bank. The 3T3-H.ras line was prepared in 
David Barnes' laboratory from plasmid pUC EJ6.6 which 
contained the activated H.ras gene under control of the 
endogenous promotor. 
Incubation of cells. 
The three cell lines , 3T3 (mouse embryo fibroblast cell), 
3T3-H.ras and Hep-G2, kept in 10% dimethyl sulfoxide at -70 °C 
were brought to -30 °C for a half hour and then room temperature 
for a half hour. The cells relieved from frozen condition were 
washed and suspended in Eagle's minimum medium. The cells 
were collected by low speed centrifugation and the medium 
containing dimethyl sulfoxide discarded. The collected cells were 
resuspended in Dulbecco's modified Eagle's medium HAMS:MEM 17 
(1:1), pH 7.4, in a 250-mL Falcon bottle, containing 1.7 pM insulin, 
and 10% fetal calf serum for the Hep G2 and 10% calf serum in 
HAMS:MEM (1:9), pH 7.4, for the 3T3 and 3T3-H.ras. The cells 
were incubated at 37 °C under an atmosphere of air/CO2(19:1) 
until complete coverage of cells on the bottom of the bottle. The 
medium was replaced when necessary, usually every two to three 
days. After complete cell coverage of the bottom of the bottle, the 
growth medium was removed and 1 ml of 0.2 % trypsin (w/v) in 
PBS, which was 1 mM in EDTA, was added. After a few minutes 
the cells were freed and the trypsin reaction was stopped by 
adding 10 ml of Eagle's minimum medium containing the calf 
serum. The cell suspension was transferred into 50 ml-plastic 
centrifuge tubes and centrifuged for 5 minutes at 600 rpm to 
collect the cells. The medium containing trypsin was removed and 
the cells were resuspended in 25 ml of choline  and methionine 
free Eagle's minimum medium. Cell number was determined by 
Coulter counter. Equal numbers (1 to 1.5x106) of cells were 
dispersed into plastic culture dishes in 2 ml of the medium to give 
a subconfluent layer. Before labelling, the cells were maintained 
overnight in the choline- and methionine-free medium to deplete 
the cellular choline and phosphocholine pools. 18 
Incorporation of [Ale-Il]choline.
The dishes of cultured cells were washed two times with 2 
ml of serum-free minimum medium to remove non-viable cells. 
Each dish of cultured cells was incubated with 2 ml of choline­
free medium that contained 10 pCi of [Me- 3H]choline chloride 
(76ci/mmol). After 1 hour the cells were washed twice with the 
chase medium, which was composed of MEM:HAMS (1:1) 
containing unlabelled 28 AM choline. The labeled cells were 
subsequently incubated for up to 4 hr with 2 ml of the chase 
medium. The chase medium was either albumin-free as a control 
or contained 5 mg/ml bovine serum albumin for the experimental 
runs. At the end of the incubation period, the medium was 
removed and the monolayer of cells washed with 1 ml of 
phosphate buffered saline. The medium and cell washings were 
combined, and centrifuged at 10000 g for 20 min to remove 
detached cells and cell debris. The supernatant was used for 
extraction and analysis of separated lipids. The cells were 
scraped from the dishes in 2 ml of distilled water with a rubber 
policeman. The cell suspension was sonicated for 30s and, after 
removal of 50 pl for protein analysis, was used for extraction and 
analysis of lipids. 19 
Extraction and analyses of cell and medium lipid.
Lipid was extracted from sonicated cell preparations and 
centrifuged media by adding 3 volume of chloroform/ 
methanol(2:1, v/v) containing the antioxidant 2,6-di-t-buty1-4­
methylphenol (50 mg,/1) using the method of Fokh et al. (24). After 
centrifugation of the extract at 300 g for 1 hour, the upper 
aqueous phase was removed and the lower chloroform phase 
washed once with 4 ml of methanol/water (1:1, v/v). A portion of 
the lower chloroform phase (0.1m1) containing lipids was 
evaporated to dryness under N2 in a scintillation vial. The residue 
was dissolved in 4 ml of scintillation fluid (0.4 %, w/v, of PPO in 
toluene: Triton X-100: H2O, 6:3:1, v/v/v) and radioactivity was 
measured with a Beckman liquid scintillation counter (LS-230). 
The remainder of the lower chloroform phase containing 
phospholipids was evaporated to small volume and applied to a 
silica-gel 60 tic. plate, which was developed in the solvent system 
chloroform/methanol/acetic acid/water (50:30:8:3 by vol.) for the 
separation of phospholipids. After the plate was air-dried, the 
radioactivity spots of PC and LPC were observed with 12 vapor 
and by radioactivity scanning of the plate using a Bioscanner (400 
imaging scanner) . The labeled PC and LPC zones were scraped 20 
from the tic plate and transferred to Pasteur pipettes that were 
plugged with a small cotton plug to retain the scrapings. The 
lipids were eluted from the SiO2 scrapings with 15 ml 
chloroform/methanol (2:1). The eluate was evaporated to a volume 
of 2 ml and an aliquot (0.1 ml) was used for radioactivity 
determination. The remaining 1.9 ml was used for phosphate 
assay. 
Phosphate assay. 
Phosphate content of phospholipids was measured by the 
modified Fiske and Subbarow method(52). The phospholipid 
samples isolated in chloroform and methanol mixture were dried 
by using N2 gas. Concentrated perchloric acid (450 pl)  was added 
to the dried sample and heated in a sand bath at 180 °C. After 1 
hour, 2.5 ml distilled water, 0.5 ml 10 % ascorbic acid, and 0.5 ml 
2.5 % ammonium molybdate were added and vortexed in order. 
The mixture was heated at 100 °C for 15 minute. After cooling to 
room temperature, the absorbance at 820 nm was measured. 
Inorganic phosphate was used as the standard. 
Protein determination. 21 
The amount of cellular protein was determined using the 
Coomassie brilliant blue G-250 from Bio-rad Laboratories. The 
sonicated cell suspension, 50pL, was dissolved in 0.1 M NaOH, 0.8 
ml, and then incubated at 55°C for 10 minute. After addition of 
0.2m1 of the Coomassie reagent, the optical density was measured 
at 595 nm. Typically, the protein content of the cells in a culture 
dish was 280 to 380 pg/mL. 22 
ILL RESULTS 
Incorporation of (3H)- choline into cellular phospholipid. 
After preincubation of cells with [Me-ql]choline, continued 
incubation in the presence of cold choline (the chase period) 
allowed the cells to metabolize and secrete the newly generated 
lipids. The extracted lipids from the cells and the incubation 
media were separated by tic. A typical scan of the radioactivity of 
the cellular lipids is shown in Figure 3. The 3H is located 
exclusively in LPC and PC with ca. 97 % being associated with 
PC. 
After the initial 1 hour pulse with the labelled substrate, the 
percent absorbed by 3T3, 3T3-H.ras, and the Hep-G2 cell lines was 
32.8±0.6, 65.3±0.4, and 51.3±1.3 % respectively. The time-dependent 
changes in radioactivity associated with cellular and secreted 
metabolites are expressed in terms of specific activity (dpm/mg 
cellular protein) so as to normalize the data for the small 
variation in cell number per dish. 
The presence of albumin in the incubation medium during 
the chase period has no marked effect on the radioactivity in the I 
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Figure 3. Radioactivity distribution of cellular ell]lipid compounds
of 3T3 cells on tic detected by automatic radioactivity Bioscanner.
The cells prelabeled with [3H]choline  were collected for lipid
analysis after further 1 hour chase with albumin. This radioactivity
distribution pattern was similar in all three cell lines regardless of
albumin addition. Zones [2]  and [5] represent LPC and PC
respectively. 24 
total cellular lipid or in either cellular PC or LPC in any of the 
cell lines as shown in Figures 4, 5, and 6. Whereas Hep G2 and 
3T3 cells continue to accumulate [3H]choline in their lipids during 
the four hour chase, PC labelling in 3T3-H.ras cells is close to a 
plateau level during the chase. 
As can be seen in Figure 3, most of the radioactivity (about 
97%) was incorporated into PC and about 3% into LPC in each of 
the three cell lines. So, it is not surprising then that the 
radioactivity incorporation patterns of total cellular [3H]lipid 
from [3H]choline in Figure 4 reflects the radioactivity profiles of 
cellular [3H]PC in Figure 5. Cellular [3H]LPC during the chase 
period (figure 6) shows some small accumulation but the presence 
of albumin has no significant effect in any of the three cell lines. 
Release of lysophosphatidylcholine and phospbatidylcholine by 
albumin as a function of time 
The most conspicuous result in this study was the 
difference in release of LPC into the albumin-containing medium 
from cultured 3T3, 3T3-H.ras, and Hep-G2 cells during the time 
course. In this experiment bovine serum albumin, free of lipid 
and other small metabolites, was used to promote LPC secretion. 25 
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Figure 4. Effect of albumin on the metabolism of cellular [3H]lipids
in three cell lines prelabelled with [Me-811]choline. The cells were 
collected at the times indicated and radioactivity was determined 
as described in the experimental section. Each point represents the
mean of two or three dishes, and the ranges were less than 10 % of
the mean. Closed symbols are for albumin-containing incubation 
media and open symbols are for albumin-free media. Li,o,o represent 
Hep G2, 3T3-H.ras, and 3T3 respectively. 26 
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Figure 5. Effect of albumin on the cellular VHIPC radioactivity 
changes in three cell lines prelabelled with Die-31111choline. The cells
were collected at the times indicated and the radioactivity was
determined as described in the experimental section. Each point
represents the mean of two or three dishes, and the ranges were less
than 10 % of the mean. Closed symbols are for albumin-containing 
incubation media and open symbols are for albumin-free media.
e,o,o represent Hep G2, 3T3-H.ras, and 3T3 respectively. 27 
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Figure 6. Effect of albumin on the cellular [11]1,PC radioactivity
changes in three cell lines prelabelled with [Ale311] choline. The
cells were collected at the times indicated. Radioactivity  was 
determined as described in the experimental section. Each point
represents the mean of two or three dishes, and the ranges were less 
than 10 % of the mean. Closed symbols are for albumin-containing 
incubation media and open symbols are for albumin-free media.
AA° represent Hep G2, 3T3-H.ras, and 3T3 respectively. 28 
Figures 7 and 8 show the radioactive scans of the separated lipids 
secreted from pre-labelled 3T3 cells during a 1 hour chase into an 
albumin-containing and an albumin-free medium respectively. It 
is clear that with albumin present the [3H]LPC is released along 
with [3H]PC whereas only [3H]PC appears in the absence of 
albumin. Figure 9 shows the influence of albumin on the release 
of total [3II]choline lipids into the media of each of the three cell 
lines during the four hour chase. Again it is clear that albumin 
has a stimulating effect upon this release of lipid with the effect 
being most marked for 3T3 cells. A time course of the albumin-
mediated release of [3H]LPC from each of the three cell lines is 
presented in Figure 10. The most striking observations are that in 
the absence of albumin no [3H]LPC is released into the medium 
from any of the three cell lines and that release of [3H]LPC from 
the 3T3 cells is much greater than that from the transformed cell 
lines. 
Clearly, with albumin present, all three cell lines release 
[3H]LPC but they do so with markedly different efficiencies. 
Tables 1 and 2 compare these efficiencies by expressing them as 
ratios of the [3H]LPC released during a 1 hour interval divided by 
the [3H]choline lipid present in the cell at the beginning of the 
interval. Table 1 shows that 3T3 secretes [3H]LPC 9-14 times more 3 T3 Medium  Lipid ( plate 1  ) P-1 L-3
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14 
Ltltitir 
NV's?  --4  r8 
CI  12  16 277
Distance of migration 
Figure 7. Radioactivity distribution of [3H]lipid secreted from 3T3
cells into an albumin containing medium.  The medium lipid
secreted from 3T3 cells prelabeled with [$H]choline were collected
for analysis after a 1 hour chase. Zones [2] and [3] represent LPC
and PC respectively. 
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Figure 8. Radioactivity distribution of [3H]lipid secreted from 3T3 cells into an albumin-free medium. The medium lipid secreted from
3T3 cells prelabeled with [3H]choline were collected for analysis
after a 1 hour chase. Zone [1] represents PC. 31 
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Figure 9. Effect of albumin on the release of rHIlipids from three
cell lines prelabelled with [Me-IfIcholine.  The medium was 
collected at the times indicated and radioactivity was determined
as described in the experimental section. Each point represents the 
mean of two or three dishes, and the ranges were less than 10 % of
the mean. Closed symbols are for albumin-containing incubation 
media and open symbols are for albumin-free media. e,0,0 represent 
Hep G2, 3T3-H.ras, and 3T3 respectively. 32 
2 80 
E 
70 
=  60
0 ­ at 50­
40 --­
30
Zt 
:a 20 
c.) 
at  ­
O
;t1  10 
041  0 
II  0  2 4  6 
Chase period (h) 
Figure 10. Effect of albumin on the release of rIEJLPC from three 
cell lines prelabelled with [Me-3H]choline. The medium was collected
at the times indicated and radioactivity was determined as
described in the experimental section. Each point represents the
mean of two or three dishes, and the ranges were less than 10 % of
the mean. Closed symbols are for albumin-containing incubation 
media and open symbols are for albumin-free media. A43,03 represent 
Hep G2, 3T3-H.ras, and 3T3 respectively. 33 
Table 1. Comparison of the efficiency of release of [4:1]-LPC from 
3T3-II.ras with that from 3T3. [8H] -LPC  was isolated from the 
medium of pre-labelled cells at the indicated times as described in
the Materials and Methods section. The  radioactivity ratios
represent the released labelled LPC during a 1 hour chase interval 
divided by the amount of labelled cellular choline-lipids present at
the begining of the interval. Each value of the ratios is the mean ± 
S.D. of two or three analyses. C.C.-lipid means total cellular choline
lipid 
Incubation  medium LPC/C.C.-lipid  medium LPC/C.C.-lipid
Time  in 3T3-H.ras (%)  in 3T3 (%) 
1  0.033±0.001  0.462±0.019 
2  0.031±0.007  0.273±0.007 34 
Table 2. Comparison of the efficiency of release rill-LPC from Hep
G2 with that from normal rat hepatocytes. For the Hep-G2, [3H] -LPC
was isolated from the medium of pre-labelled cells at the indicated
times as described in the Materials and Methods  section. The 
radioactivity ratio represent the released labelled LPC during a 1
hour chase interval divided by the amount of labelled cellular 
choline-lipids present at the begining of the interval. Each value of
the ratios is the mean t S.D. of two or three analyses. C.C.-lipid
means total cellular choline-lipid. 
Incubation  medium LPC/C.C.-lipid  medium LPC /C.C. -lipid'
Time  in Hep G2 (%)  in rat hepatocytes (%) 
1  0.04910.000  1.71±0.17 
2  0.01910.009  1.4310.14 
+, calculated from previously published data obtained under the
same experimental conditions (35). 35 
effectively than that from 3T3-H.ras. In Table 2, the results for 
Hep G2 are compared with those for rat hepatocytes calculated 
from previously published data obtained under the same 
conditions as described in this research. Rat hepatocytes secrete 
LPC 35-75 times more effectively than do Hep-G2 cells. It is 
obvious that Hep G2 is the least efficient in [8H]LPC secretion 
among these cells while rat hepatocytes are the most efficient. 
Albumin also stimulates PC secretion into the chase 
medium as well as LPC. The effect of albumin on the release of 
[$il]PC from cultured 3T3, 3T3-H.ras, and Hep G2 prelabelled with 
[$Il]choline is depicted in Figure 11. It is clear that PC is secreted 
into the medium in each of the three cell lines in the absence of 
albumin. However, Hep G2 secretes PC most effectively of the 
three cell lines. It is noteworthy that albumin is more stimulatory 
on the 3T3 and 3T3-H.ras cells than Hep G2 cells. At 4 hours of 
chase PC secretion by albumin from Hep G2 is increased about 25 
% whereas the increase is about 60 % and 40 % respectively for 
3T3-H.ras and 3T3 cells. Even so, the liver cell line is much more 
efficient at [3H]PC secretion than the two fibroblast lines with or 
without albumin present. Tables 3 and 4 show that the 
transformed cells release [3H]PC less effectively than non-
transformed cells in the presence of albumin. Rat hepatocytes 36 
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Figure 11. Effect of albumin on the release of [3H]PC from three cell 
lines prelabelled with [Me- 3Hlcholine. The medium was collected at
the times indicated and radioactivity was determined as described
in the experimental section. Each point represents the mean of two
or three dishes, and the ranges were less than 10 % of the mean.
Closed symbols are for albumin-containing incubation media and
open symbols are for albumin-free media. A,D,o represent Hep G2,
3T3-H.ras, and 3T3 respectively. 37 
Table 3. Comparison of the efficiency of release of rifjPC from 3T3­
H.ras with that from 3T3. [$il]PC was isolated from the medium of
pre-labelled cells at the indicated times  as described in the 
Materials and Methods section. The radioactivity ratios represent
the released labelled PC during a 1 hour chase interval divided by
the amount of labelled cellular choline-lipids  present at the
beginning of the interval. Each value of the ratios is the mean ± S.D. 
of two or three analyses. C.C.-lipid means total cellular choline lipid 
Incubation  medium PC/C.C.-lipid  medium PC/C.C.-lipid
Time  in 3T3-H.ras (%)  in 3T3 (%) 
1  0.19±0.01  0.30±0.05 
2  0.19t0.02  0.32±0.04 38 
Table 4. Comparison of the efficiency of release of ell]PC from Hep
G2 with that from a normal rat hepatocytes. For the Hep-G2, [311]PC 
was isolated from the medium of pre-labelled cells at the indicated
times as described in the Materials and Methods section. The 
radioactivity ratios represent the released labelled PC during a 1 
hour chase interval divided by the amount of labelled cellular
choline-lipids present at the beginning of the interval. Each value
of the ratios is the mean t S.D. of two or three analyses. C.C.-lipid
means total cellular choline lipid 
Incubation  medium PC/C.C.-lipid  medium PC /C.C. -lipid`
Time  in Hep G2 (%)  in rat hepatocytes ( %) 
1  0.35±0.05  1.33±0.13 
2  0.38±0.01  1.07±0.11 
+; These values were calculated from the published data (35). 39 
secrete PC 2.8-3.8 times more effectively than Hep G2 whereas 
3T3 cells secrete PC 1.6 times more effectively than 3T3-H.ras. 
Lysophosphatidylcholine and phosphatidylcholine secretion 
pools. 
Comparison of the specific radioactivity of the cellular and 
secreted PC and LPC were measured by separation of the two 
lipids and quantitation of their 3H radioactivities and phosphate 
contents. In the case of Hep G2 and 3T3-H.ras cells, the amount of 
LPC secreted into the medium was too small to allow phosphate 
measurement. I was only able to measure the radioactivity of 
secreted LPC and PC, which are shown in Figures 10 and 13. 
However, in the case of 3T3 cells, the phosphate content of PC 
and LPC secreted into the medium were measurable. Tables 5 
and 6 show specific radioactivities of cellular and medium PC 
and LPC respectively. As we can see from the tables, the specific 
radioactivity of cellular PC was approximately the same as that 
of secreted PC. However, the specific radioactivity of LPC 
secreted into the medium was markedly lower than that of 
cellular LPC or of cellular PC. This LPC specific radioactivity 
also shows a steady increase during the incubation time while the 40 
specific radioactivity of cellular PC shows little variation. 41 
Table 5. Specific radioactivity of medium and cellular [3H]PC of 3T3
cells.  PC was isolated from prelabelled 3T3 cells and from the 
incubation media with albumin at the times indicated.  Specific
radioactivities of medium and cellular phosphatidylcholine were 
determined from radioactivity incorporated and phosphate amount 
of phosphatidylcholine as described under "Material and Methods".
Each value of specific radioactivity is the mean ± S.D. of two 
analyses. 
Time(h)  Cellular PC (dpm/nmol)  Medium PC (dpm/nmol) 
0  1.01(t0.13)x104 
1  1.39(±0.09)x104  1.06(10.63)x104 
2  1.52(±0.04)x104  1.13(10.26)x10° 
4  1.44(±0.06)x104  1.34(t0.15)x104 42 
Table 6. Specific radioactivity of medium and cellular [3H]LPC of 
3T3 cells. LPC was isolated from prelabelled 3T3 cells and from the
incubation media with albumin at the times indicated. Specific
radioactivities of medium and cellular lysophosphatidylcholine were 
determined from radioactivity incorporated and phosphate amount
of lysophosphatidylcholine as described under "Material and
Methods". Each value of specific radioactivity is the mean ± S.D. of 
two analyses. 
Time(h)  Cellular LPC (dpm/nmol)  Medium LPC (dpm/nmol) 
0  9.22(±0.17)x103 
1  1.20(±0.14)x104  5.28(±0.41)x103 
2  1.36(±0.15)x104  7.58(±0.09)x103 
4  1.31(±0.13)x104  8.41(±1.28)x103 43 
IV. Discussion 
The 3T3 cell line established by G. Todaro and H. Green in 
1962 from disaggregated Swiss mouse embryos has sensitivity to 
contact inhibition of cell proliferation (53). The 3T3-H.ras is a 
Harvey Sarcoma virus transformed nonproducer cell line. These 
cells have altered properties in vitro and lack contact inhibition 
of cell division (56). Hep G2, a liver cell line derived from a 
human hepatoblastoma, has been found to express a wide variety 
of liver-specific lipid metabolic reactions (40) and has similar 
lipid composition with normal human hepatocytes (41). 
In this research, we compared LPC release from 3T3 cells 
with that from 3T3-H.ras cells. In addition, LPC release from Hep 
G2 is compared with previously published results on the rat 
hepatocytes (24-28). 
3T3 -H.ras cells more actively incorporate rificholine than 3T3 
cells and Hep G2. 
The amount of [3H]choline taken up by the three cell lines 
during the labelling period is obtained from the sum of the 3H 
content of the cellular lipid and water-soluble fractions. 44 
Expressed as a percent of the [$Il]substrate provided, these values 
are 32.8, 65.3, and 51.3 for 3T3, 3T3-H.ras, and Hep G2 
respectively. Generally, choline uptaken is much more efficient in 
the transformed cell lines. In addition, by comparing this amount 
of radioactivity present in the cells' lipids at the start of the chase 
period (figure 4), it is clear that the 3T3-H.ras cells also 
incorporate this absorbed substrate into lipid more efficiently. It 
is not unexpected that transformed cells might be more active in 
PC synthesis than untransformed cells since their growth rate 
would be higher. 
During the chase period, the 3H content of cellular PC and 
LPC increases in Hep G2 and 3T3 cells but is relatively constant 
in 3T3-H.ras. Since the cytidylyltransferase is the rate-limiting 
enzyme in mammalian PC synthesis, phosphocholine is the major 
metabolic pool in the pathway. my attempt to minimize the size of 
this pool by incubation in a choline- and methionine-free medium 
prior to labelling appears to have been successful for 3T3-H.ras 
cells but less for Hep G2 and 3T3. Such differences in the size of 
the endogenous phosphocholine pools among the three cell lines 
would explain the higher incorporation of label into PC by 3T3­
H.ras and also the steadily increasing label in PC during the 
chase period in Hep G2 and 3T3. 45 
More efficient release of PHILPC and [3H]PC by albumin from
nontransformed cells than from transformed cells.
After Sekas et al reported that an isolated rat liver directly 
secreted LPC in the presence of albumin, LPC secretion from 
isolated rat hepatocytes by albumin was studied (31-38). All of the 
research showed that rat hepatocytes strongly secreted LPC into 
albumin-containing medium while there was no secretion of LPC 
in the absence of albumin. Curiously, Brindley et al reported that 
ovine hepatocytes do not display the capacity to release LPC (38). 
Obviously, in transformed cells, choline and unsaturated fatty 
acid are always in demand in order to maintain a rapid growth 
rate. Our results (figure 10) show that not only Hep G2, the 
transformed liver cell line, but also the two cell lines derived 
from fibroblasts, 3T3 and 3T3-H.ras, release LPC into the medium 
in the presence of albumin but no LPC secretion occurs in its 
absence. It has been reasonably argued that physiologically the 
extra-essential fatty acid (unsaturated fatty acid) and choline in 
the untransformed cells may be transported to other tissues 
which need the fatty acid and choline. 
A comparison of the efficiency with which [311]LPC is46 
released from the three cell lines is shown in Table 1. The amount 
of radioactive LPC appearing in the medium during a 1 hour time 
period as a percentage of the radioactive choline lipid in the cells 
at the beginning of the time period is a measure of the efficiency 
of release of this newly synthesized lipid. Clearly, the normal cell 
line, 3T3, is much more efficient compared with the transformed 
cells. Comparison of the Hep G2 data with that calculated from 
previously published work on the rat hepatocyte is shown in 
Table 2. Again the normal cell line releases [311]LPC more readily 
than does the transformed celL Though Hep G2 is a human liver 
cancer cell and is different from the rat liver cell, it may give an 
insight into this process in a tumorous rat hepatocyte because PC 
metabolism of human and rat hepatocytes are similar (1). Since I 
was unable to measure the phosphate content of the secreted LPC 
for the two transformed cells, we are not able to measure these 
secretion efficiencies in terms of nmoles of LPC relative to 
nmoles of cellular choline lipid. Nevertheless, the differences 
between normal and transformed cells with respect to the release 
of newly synthesized LPC are significantly large. 
The mechanism for LPC secretion is not well understood. It 
is generated by phospholipase A activities which have been found 
in almost every mammalian cell (16). In rat hepatocytes, 47 
phospholipases Al and A2 are found in the plasma membrane, 
microsomes, Golgi membrane, mitochondria, lysosomes, and 
cytosol (16). Many researchers in this field have suggested that 
LPC arises mainly by the action of phospholipase Al on PC 
because of the unsaturated nature of the secreted LPC (31, 32, 34­
38). A major site for the origin of the LPC may be the plasma 
membrane, since lysophospholipase, the LPC-deacylating activity, 
does not occur in the plasma membrane (16). LPC so formed may 
then be sequestered into the medium by attachment to albumin 
or be reacylated to PC. 
Albumin is the most abundant protein in human plasma, 
constituting about 50 percent (42±3.5 g/L) of the plasma proteins 
in the human. The protein exists as a monomer with a molecular 
weight of 66,200 and specifically binds a wide variety of biological 
materials such as LPC, PC,fatty acid, and some cationic and 
anionic ligands. It has been reported that the stoichiometry of 
binding is one molecule of LPC to one albumin molecule with an 
association constant, KA=4.3x104 (55). Furthermore, the binding 
site for LPC is different from that for fatty acid. 
The basis for the more efficient release of newly formed 
LPC from normal cells compared with transformed cells is not 
clear. As Brindley et al pointed out, this LPC, which contains 48 
mostly unsaturated fatty acids, would supply other organs with 
choline and unsaturated fatty acids (34). We may assume that the 
tumor cell, in order to maintain rapid growth, might restrict the 
loss of materials such as choline and unsaturated fatty acids, 
which would be essential for new membrane synthesis. However, 
it is not clear why 3T3, and particularly 3T3-H.ras cells release 
PC into the medium even in the absence of albumin (figure 11) 
unless this PC is a component of a lipoprotein. The fibroblast, 
being an undifferentiated cell, may possess an active lipoprotein 
secretion pathway. The release of PC by Hep G2 is less surprising 
since Hep G2 is an hepatocyte cell line whose function it is to 
secrete lipoproteins. 
With regard to the cell surfaces of the three cell lines, it is 
likely that the topography of the cell surface plays a role in the 
sequestering of LPC by albumin. When 3T3 cells are transformed 
by oncogenic viruses or chemical carcinogens, the transformed 
cells have an altered and simpler oligosaccharide moiety of their 
complex ganglioside, an acidic glycolipid (57). It has also been 
observed that the oligosaccharide moieties of tumor cell 
glycoproteins are different and simpler from those found in 
normal cell plasma membranes (51). Thus, the association of 
albumin with the cell surface may be affected in such a way that 49 
there is a less effective binding of LPC from the transformed cell.
PC is secreted by the three cell lines regardless of the 
presence of albumin (figure 11). In Hep G2 (40) and rat 
hepatocytes (33,34), the PC secretion was reported as a normal 
function of the cell in which PC is secreted as one component of 
lipoprotein. The PC secretion from 3T3 cells may also be a 
lipoprotein component but that remains to be established. More 
than one explanation can be offered for the stimulation of PC 
secretion by albumin in the three cell lines. The most likely is 
that it results from the binding to albumin of PC in the plasma 
membrane. For this to occur, a tight association of albumin with 
the membrane would be needed. Differences in the effective 
association of albumin with the cell surface between transformed 
and normal cells may also account for the less efficient release of 
newly formed PC from the transformed cells (table 3 and 4). Thus, 
both LPC and PC release may be governed by the same 
mechanism. If the PC that appears in the medium has a 
lipoprotein source as is the case for Hep G2, it is conceivable that 
there may be an enhanced lipoprotein secretion in response to 
albumin. In the case of rat hepatocytes the stimulation of PC 
release by albumin is only slight, even less than that shown by 
Hep G2 (35). This might be anticipated if both sets of hepatocytes 50 
are operating at or near maximum capacity for lipoprotein 
secretion under albumin-free conditions. 
A discrete pool of PC is selected for the synthesis and release of 
LPC in 3T3 cells. 
The specific radioactivity of cellular LPC in 3T3 cells was 
lower than the specific radioactivity of cellular PC as shown in 
Tables 5 and 6. Since the pool size of LPC is always very small, it 
is clear that cellular LPC is generated from newly synthesized 
and endogenous PC. More surprising is the observation that the 
specific radioactivity of the medium LPC was about 40 % of that 
of the cellular LPC at 1 hour of incubation and only increased to 
66 % after 4 hours. Clearly, the pools of newly synthesized PC and 
LPC are not the major sources for the LPC that is secreted and 
this secretory pool only slowly equilibrates with the LPC 
generated from cellular PC. Brindley et al reached the same 
conclusion concerning separate pools in LPC production from 
their observation that LPC secreted from the female rat 
hepatocyte has a low content of arachidonic acid despite a 
relatively higher proportion of this acid in the cellular PC (38). 51 
These observations are in sharp contrast to those made with
cellular and secreted PC described below.
The specific radioactivity of PC made from [3H]choline was 
approximately equal in 3T3 cells and the medium as shown in 
Table 4. This is not surprising considering the data reported from 
several studies on the rapid rate of equilibration of PC among 
microsomal, Golgi, and plasma membranes of rat liver (58). Other 
studies have shown a tv.i= 2 minute at 25 °C for transfer of PC 
from the endoplasmic reticulum (the site of synthesis of PC) to 
the plasma membrane in Chinese hamster ovary cells (59). It is 
clear that the pathways by which PC and LPC appear in the 
medium originate from distinctly different pools of cellular PC. In 
support of the existence of different pools of cellular PC, Vance et 
al have found that in the case of lipoprotein secretion by cultured 
rat hepatocytes that there is a preference for PC made from 
choline rather than ethanolamine (50). In addition, from PC and 
phospholipid secretion using 31I-serine, they concluded that there 
is no random and homogeneous labelling of phospholipid pools 
from radioactive precursors. 52 
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